PE20151883A1 - Solucion electrolitica oral que contiene lactoferrina y usos de la misma - Google Patents

Solucion electrolitica oral que contiene lactoferrina y usos de la misma

Info

Publication number
PE20151883A1
PE20151883A1 PE2015001945A PE2015001945A PE20151883A1 PE 20151883 A1 PE20151883 A1 PE 20151883A1 PE 2015001945 A PE2015001945 A PE 2015001945A PE 2015001945 A PE2015001945 A PE 2015001945A PE 20151883 A1 PE20151883 A1 PE 20151883A1
Authority
PE
Peru
Prior art keywords
oral
electrolytic solution
lactopherrin
same
solution containing
Prior art date
Application number
PE2015001945A
Other languages
English (en)
Inventor
John D Alvey
Juan M Gonzalez
Dattatreya Banavara
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of PE20151883A1 publication Critical patent/PE20151883A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C17/00—Buttermilk; Buttermilk preparations
    • A23C17/02—Buttermilk; Buttermilk preparations containing, or treated with, microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE REFIERE A UNA SOLUCION ELECTROLITICA ORAL QUE COMPRENDE: A) UN ELECTROLITO TAL COMO SODIO, POTASIO Y CLORURO; B) UNA FUENTE DE CARBOHIDRATOS; C) DE 15 MG/ 100 ML A 150 MG / 100 ML DE LACTOFERRINA; D) UN PROBIOTICO TAL COMO LACTOBACILLUS RHAMNOSUS GC; E) VITAMINA B3; Y F) UNA FUENTE DE ZINC; EN DONDE DICHA SOLUCION ELECTROLITICA ORAL TIENE UNA OSMOLALIDAD DE 100 mOsm/KG DE AGUA HASTA 250 mOsm/KG DE AGUA. TAMBIEN SE REFIERE A METODOS PARA LA REDUCCION DE LA DURACION DE LOS SINTOMAS DE DIARREA Y REDUCIR LA IRRITACION GASTROINTESTINAL EN UN SUJETO PEDIATRICO, PROPORCIONANDO DICHA SOLUCION ELECTROLITICA ORAL
PE2015001945A 2013-03-11 2014-02-11 Solucion electrolitica oral que contiene lactoferrina y usos de la misma PE20151883A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/794,014 US20140255365A1 (en) 2013-03-11 2013-03-11 Oral Electrolyte Solution Containing Lactoferrin and Uses Thereof

Publications (1)

Publication Number Publication Date
PE20151883A1 true PE20151883A1 (es) 2016-01-17

Family

ID=50239940

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015001945A PE20151883A1 (es) 2013-03-11 2014-02-11 Solucion electrolitica oral que contiene lactoferrina y usos de la misma

Country Status (14)

Country Link
US (1) US20140255365A1 (es)
EP (1) EP2968305A1 (es)
CN (1) CN105120888A (es)
AR (1) AR095082A1 (es)
AU (1) AU2014228654B2 (es)
BR (1) BR112015020864A2 (es)
CA (1) CA2904221A1 (es)
HK (1) HK1218070A1 (es)
MX (1) MX2015011540A (es)
PE (1) PE20151883A1 (es)
PH (1) PH12015501803A1 (es)
RU (1) RU2015132613A (es)
SG (1) SG11201505529SA (es)
WO (1) WO2014143471A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
GR1009632B (el) 2018-07-09 2019-10-25 Ιουλια Κλεωνος Τσετη Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
EP0744901B1 (en) 1994-02-16 2001-12-05 Pharming Intellectual Property BV Isolation of lactoferrin from milk
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
EP1480524B1 (en) 2002-03-07 2013-04-17 Upfront Chromatography A/S A process of isolating lactoferrin
EP1940454A4 (en) * 2005-09-28 2012-01-04 Ventria Bioscience ORAL PREPARATION FOR ENTERIC DISORDERS AND / OR REHYDRATION
EP1974735A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
IT1392672B1 (it) * 2009-01-12 2012-03-16 Wyeth Consumer Healthcare S P A Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina
US20120171328A1 (en) 2011-01-05 2012-07-05 Dattatreya Banavara Composition comprising heat labile milk proteins and process for preparing same
US20130095204A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions

Also Published As

Publication number Publication date
HK1218070A1 (zh) 2017-02-03
MX2015011540A (es) 2016-02-05
PH12015501803A1 (en) 2015-11-09
CN105120888A (zh) 2015-12-02
CA2904221A1 (en) 2014-09-18
WO2014143471A1 (en) 2014-09-18
EP2968305A1 (en) 2016-01-20
AU2014228654A1 (en) 2015-08-06
BR112015020864A2 (pt) 2017-07-18
AR095082A1 (es) 2015-09-16
RU2015132613A (ru) 2017-04-13
AU2014228654B2 (en) 2018-02-15
US20140255365A1 (en) 2014-09-11
SG11201505529SA (en) 2015-08-28

Similar Documents

Publication Publication Date Title
MX2021015825A (es) Formulaciones de anticuerpos estables acuosas.
AR100925A1 (es) Composiciones orales que contienen fuentes de ión de zinc, estaño y fluoruro
AR094012A1 (es) Composiciones estables con peroxido para el cuidado oral
CL2014000786A1 (es) Composicion que comprende un péptido que se une de manera inmunoespecífica a la secuencia a relacionada con el polipeptido mhc de clase i (mica); método para obtener células inmunes dirigidas contra un antígeno propio de un individuo.
AR095104A1 (es) Método para disminuir el dolor articular inducido por el ejercicio en mamíferos no artríticos
CL2019002190A1 (es) Reducción de la viscosidad de formulaciones farmacéuticas que comprende una proteína terapéutica a una concentración de al menos 70 mg/ml, donde la proteína terapéutica no es un anticuerpo (divisional solicitud 201700984)
MX2016008977A (es) Formulaciones farmaceuticas de insulina aspart estabilizadas.
UA115811C2 (uk) Стабільний розчин об'єднаних баклофену, сорбіту і налтрексону для перорального застосування
PE20150083A1 (es) Formulacion de ibuprofeno inyectable
PH12016501005A1 (en) Anti-malodor oral care composition
MX370990B (es) Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos.
CL2016002318A1 (es) Composición farmacéutica en forma de solución que comprende un portador líquido que comprende agua y entre 20% y 95% de uno o mas alcoholes y citrato de sildenafil disuelto en dicho portador líquido a una concentración de entre 7 y 125 mg/ml; métodos para obtenerla; forma de dosificación oral; forma de dosificación bucal; kits.
PL402029A1 (pl) Anoda, zwłaszcza do ogniw fotoelektrochemicznych, i zastosowanie materiału eutektycznego
AR088918A1 (es) Composiciones antitranspirantes anhidras
ES2495666A2 (es) Uso de derivados con enlaces c-o-p en pacientes con fallo renal
AR100028A1 (es) Composiciones nutricionales que contienen ácido estearidónico
AR098386A1 (es) Formulación para gonadotropinas
SA521420975B1 (ar) صيغ ذات تركيبة نانوية لتوصيل سيليبينين وعناصر نشطة أخرى لعلاج أمراض العين
PE20151883A1 (es) Solucion electrolitica oral que contiene lactoferrina y usos de la misma
CL2015001544A1 (es) Método para fabricar sal mineral y producto de sal mineral
PE20151432A1 (es) Formulaciones de lorazepam de liberacion sostenida
MD201Y (en) Medium for cryoconservation of human sperm
PH12017501603A1 (en) Solid oral care composition
PH12015500708A1 (en) Agent for enhancing immunity containing glutathione
UY34895A (es) Formulaciones estabilizadas de etanercept

Legal Events

Date Code Title Description
FA Abandonment or withdrawal